The safety of combining Endostar with concurrent chemoradiotherapy for the treatment of locally advanced cervical cancer and the evaluation of its anti-angiogenic effects via transrectal contrast-enhanced ultrasound.
- DOI
- 10.3389/fonc.2025.1514425
- Published
- 2025
- Container
- Frontiers in oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2025.1514425,
title = {The safety of combining Endostar with concurrent chemoradiotherapy for the treatment of locally advanced cervical cancer and the evaluation of its anti-angiogenic effects via transrectal contrast-enhanced ultrasound.},
author = {Wu F and Lu Z and Que J and Ma S and Jiang L and Tang X and Zheng C and Zhou L and Huang Q and Zhang Y},
year = {2025},
journal = {Frontiers in oncology},
doi = {10.3389/fonc.2025.1514425},
url = {https://doi.org/10.3389/fonc.2025.1514425}
}RIS
TY - JOUR TI - The safety of combining Endostar with concurrent chemoradiotherapy for the treatment of locally advanced cervical cancer and the evaluation of its anti-angiogenic effects via transrectal contrast-enhanced ultrasound. AU - Wu F AU - Lu Z AU - Que J AU - Ma S AU - Jiang L AU - Tang X AU - Zheng C AU - Zhou L AU - Huang Q AU - Zhang Y PY - 2025 JO - Frontiers in oncology DO - 10.3389/fonc.2025.1514425 UR - https://doi.org/10.3389/fonc.2025.1514425 ER -
APA
F, W., Z, L., J, Q., S, M., L, J., X, T., C, Z., L, Z., Q, H., & Y, Z. (2025). The safety of combining Endostar with concurrent chemoradiotherapy for the treatment of locally advanced cervical cancer and the evaluation of its anti-angiogenic effects via transrectal contrast-enhanced ultrasound.. Frontiers in oncology. https://doi.org/10.3389/fonc.2025.1514425
Source records
- pubmed · retrieved 2026-09-25T08:17:51.938Z